GKIM
DCPH

GW&K Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

GW&K Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-340
Closed -$3K – 854
2021
Q4 		$3K Sell
340
-193,848
-100% -$3.65M ﹤0.01% 382
2021
Q3 		$6.6M Sell
194,188
-3,880
-2% -$124K 0.06% 240
2021
Q2 		$7.25M Sell
198,068
-4,010
-2% -$155K 0.06% 242
2021
Q1 		$9.06M Buy
+202,078
New +$9.41M 0.08% 220

Other funds holding DCPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

GW&K Investment Management's DCPH Position: Q1 2022 in Review

GW&K Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 340 shares — an estimated $3K sold.

GW&K Investment Management first reported a position in DCPH in Q1 2021 and held it in 4 quarters. The position peaked at $9.06M in Q1 2021. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

  • GW&K Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • GW&K Investment Management sold 340 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $3K.
  • GW&K Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • GW&K Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $9.06M in Q1 2021.
  • 123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on GW&K Investment Management's 13F filing for Q1 2022, filed 9 May 2022.